Aptorum Group Limited
APM
$2.76
-$0.12-4.17%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
8/29/2024
-
Zolmax
8/28/2024
-
Ticker Report
8/13/2024
-
Ticker Report
8/8/2024
-
Zolmax
8/8/2024
-
Ticker Report
7/28/2024
-
Zolmax
7/13/2024
-
Ticker Report
7/1/2024
-
Zolmax
6/23/2024
-
Ticker Report
4/30/2024
-
TipRanks Financial Blog
4/30/2024
-
Business Wire
4/13/2024
-
Ticker Report
3/27/2024
-
Ticker Report
3/19/2024
-
The Fly
3/19/2024
-
The Fly
3/12/2024
-
The Fly
3/12/2024
-
The Fly
3/8/2024
-
The Fly
3/8/2024
-
The Fly
3/7/2024
-
Seeking Alpha - Healthcare
3/7/2024
-
SeekingAlpha.com: All News
3/7/2024
-
The Fly
3/7/2024
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, April 30, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of Dec 16 and 20 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 20 8092 9299
Address
17 Hanover Square
London, W1S 1BN
London, W1S 1BN
Country
Year Founded
Business Description
Sector
Aptorum Group Limited, through its subsidiaries, operates as a clinical stage biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutic products...
more
